fecal microbiota transplatation
Sponsors
Ohmiya Naoki
Conditions
1)Clostridium difficile infection 2)Crohn disease, ulcerative colitis 3)Chronic Enteropathy associatMalignant tumors for which immune check point inhibitors are indications
Phase 2
Fecal microbiota transplantation for intractable gastrointestinal diseases
(FEMIGI study)
RecruitingJPRN-jRCTs041190021
Start: 2019-04-23Target: 100Updated: 2026-06-29
Fecal microbiota transplantation for immune checkpoint inhibitors(FMT for ICI)
Active, not recruitingJPRN-jRCTs041200003
Start: 2020-04-17Target: 50Updated: 2026-06-29